Search Results - "Gong, Anna J"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2

    Prospective Study of Polytetrafluoroethylene-Covered Microplugs and Detachable Coils for Embolization of Pulmonary Arteriovenous Malformations: Technical Results, Procedure Times, and Costs by Gong, Anna J., Bosworth, Eugene C., Garg, Tushar, Weiss, Clifford R.

    “…To determine time to occlusion and procedure costs of embolization of pulmonary arteriovenous malformations (PAVMs) using a polytetrafluoroethylene-covered…”
    Get full text
    Journal Article
  3. 3

    Assessing the Psychometric Validity of the Epistaxis Severity Score: Internal Consistency and Test–Retest Reliability by Gong, Anna J., Bolsegui, Marisabel Linares, Lee, Emerson E., Mathai, Stephen C., Weiss, Clifford R.

    Published in American journal of rhinology & allergy (01-01-2024)
    “…Background The Epistaxis Severity Score (ESS) is the gold-standard patient-reported outcome measure for evaluating nosebleed severity in patients with…”
    Get full text
    Journal Article
  4. 4

    Interval Breast Cancers Versus Screen Detected Breast Cancers: A Retrospective Cohort Study by Ambinder, Emily B., Lee, Emerson, Nguyen, Derek L., Gong, Anna J., Haken, Orli J., Visvanathan, Kala

    Published in Academic radiology (01-09-2023)
    “…Mammographic screening detects most breast cancers but there are still women diagnosed with breast cancer between annual mammograms. We aim to identify…”
    Get full text
    Journal Article
  5. 5

    Comparison of Outcomes for One-View Asymmetries Recalled From Digital Breast Tomosynthesis Versus Full-Field Digital Mammography Screening Examinations by Gong, Anna J, Nguyen, Derek L, Lee, Emerson E, Mullen, Lisa A, Myers, Kelly S, Oluyemi, Eniola, Ambinder, Emily B

    Published in American journal of roentgenology (1976) (01-11-2022)
    “…Recall rates are lower for digital breast tomosynthesis (DBT) than for full-field digital mammography (FFDM). This difference could have important implications…”
    Get full text
    Journal Article
  6. 6

    Racial and Ethnic Disparities among Participants in Hepatocellular Carcinoma Clinical Studies Evaluating Transarterial Therapies by Garg, Tushar, Gong, Anna J., Khalil, Adham, Gowda, Prateek C., Weinstein, Robert M., Holly, Brian P., Weiss, Clifford R.

    “…To evaluate the racial and ethnic representation of transarterial therapy for hepatocellular carcinoma (HCC) clinical trials in the United States. The…”
    Get full text
    Journal Article
  7. 7

    Health-Related Quality of Life Outcome Measures in Individuals With Hereditary Hemorrhagic Telangiectasia: A Scoping Review by Gong, Anna J., Garg, Tushar, Khalil, Adham, Gowda, Prateek C., Mathai, Stephen C., Rowan, Nicholas R., Merlo, Christian A., Weiss, Clifford R.

    Published in American Journal of Rhinology & Allergy (01-01-2024)
    “…Background Studies evaluating health-related quality of life (HRQOL) in patients with hereditary hemorrhagic telangiectasia (HHT) have expanded rapidly in the…”
    Get full text
    Book Review Journal Article
  8. 8

    Whole-lesion assessment of volume and signal changes after sclerotherapy of extremity venous malformations by Khalil, Adham, Laguna, Amanda, I Mehta, Tej, Gowda, Prateek C, Gong, Anna J, Weinstein, Robert M, Garg, Tushar, Ring, Natalie Y, England, Ryan W, George Linguraru, Marius, Jones, Craig K, Weiss, Clifford R

    Published in European journal of radiology (01-05-2024)
    “…•MRI-based volumetric analysis can assess outcomes of PS in extremity VMs.•Volumetric assessment of volume and SI change on T2-WI after PS is feasible.•VM…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Risk factors and clinical features associated with basal ganglia manganese deposition in patients with hereditary hemorrhagic telangiectasia by Weinstein, Robert M., Gowda, Prateek C., Yuan, Frank, Khalil, Adham, Motaghi, Mina, Garg, Tushar, Gong, Anna J., Lin, Doris D., Weiss, Clifford R.

    Published in Clinical imaging (01-09-2023)
    “…T1-hyperintensity of the basal ganglia (BG) due to manganese deposition is a known radiologic finding in patients with hereditary hemorrhagic telangiectasia…”
    Get full text
    Journal Article
  11. 11

    Impact of Patient Navigation on Reducing Breast Imaging Disparities and Applications in the COVID-19 Era by Gong, Anna J, Lee, Emerson E, Visvanathan, Kala, Oluyemi, Eniola T

    Published in Journal of breast imaging (22-05-2023)
    “…Abstract The coronavirus (COVID-19) pandemic has impacted breast cancer screening with concerns that this may lead to increased overall breast cancer mortality…”
    Get full text
    Journal Article
  12. 12

    Vascular findings in CTA body and extremity of critically ill COVID-19 patients: commonly encountered vascular complications with review of literature by Lee, Emerson E., Gong, Anna J., Gawande, Rakhee S., Fishman, Elliot K., Vadvala, Harshna V.

    Published in Emergency radiology (01-04-2022)
    “…The purpose of our review is to discuss the role of CT angiography (CTA) in evaluating a variety of vascular complications in critically ill COVID-19 patients…”
    Get full text
    Journal Article
  13. 13

    Clinical and molecular characterization of patients with hereditary hemorrhagic telangiectasia: Experience from an HHT Center of Excellence by Latif, Muhammad A., Sobreira, Nara Lygia D., Guthrie, Kelsey S., Motaghi, Mina, Robinson, Gina M., Shafaat, Omid, Gong, Anna J., Weiss, Clifford R.

    “…In this retrospective single‐center study, we evaluated whether/how pathogenic/likely pathogenic variants of three hereditary hemorrhagic telangiectasia…”
    Get full text
    Journal Article
  14. 14

    Diversity and Inclusion in Breast Imaging and Radiology at Large: What Can We Do to Improve? by Haken, Orli J., Gong, Anna J., Ambinder, Emily B., Myers, Kelly S., Oluyemi, Eniola T.

    “…Purpose of Review A racially and ethnically diverse healthcare workforce leads to increased access to care and better health outcomes. Radiology and…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Clinical Emergence of Low-flow Vascular Malformations After Vaccination Against SARS-CoV-2: A Case Series by Gong, Anna J., Khalil, Adham, Weiss, Clifford R.

    “…Studies have demonstrated that all 3 of the FDA-approved COVID-19 vaccines (Pfizer-BioNTech, Moderna, and Johnson & Johnson) are effective at reducing…”
    Get full text
    Journal Article